Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.18
Delayed Data
As of May 22
 -0.04 / -1.80%
Today’s Change
1.53
Today|||52-Week Range
4.20
+18.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues2.7M3.7M1.4M5.1M
 
 
 
 
 
Cost of Goods Sold805.0K1.0M855.0K2.4M
 
 
 
 
 
Depreciation And Amortization800.0K790.0K722.0K--
 
 
 
 
 
Operating ExpensesGross Income1.1M1.9M-193.0K2.7M
 
 
 
 
 
General Expenses8.6M10.1M8.9M8.7M
 
 
 
 
 
Research And Development7.1M8.1M6.5M6.8M
 
 
 
 
 
Total Operating Expenses10.2M11.9M10.4M11.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-8.2M-9.0M-6.0M
 
 
 
 
 
Interest Expense On Debt874.0K938.0K1.4M1.2M
 
 
 
 
 
Other Expenses2.1M1.0M2.0M1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.1M-8.0M-8.5M-6.0M
 
 
 
 
 
Net Income-6.1M-8.0M-8.5M-6.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS92.8M93.0M93.6M93.2M
 
 
 
 
 
Shares To Calculate EPS Diluted92.8M93.0M93.6M93.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.09-$0.09-$0.06
 
 
 
 
 
EPS Diluted-$0.07-$0.09-$0.09-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account